As filed with the Securities and Exchange Commission on October 9, 2003
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT NO. 3 TO
SCHEDULE TO
TENDER OFFER STATEMENT
UNDER SECTION 14(D)(1) OR 13(E)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934
AMN HEALTHCARE SERVICES, INC.
(Name of Subject Company and Filing Person)
COMMON STOCK, PAR VALUE $0.01 PER SHARE OPTIONS TO PURCHASE COMMON STOCK
(Title of Class of Securities) (Title of Class of Securities)
001744101 NONE
(CUSIP Number of Class of Securities) (CUSIP Number of Class of Securities)
DONALD R. MYLL
CHIEF ACCOUNTING OFFICER AND CHIEF FINANCIAL OFFICER
AMN HEALTHCARE SERVICES, INC.
12400 HIGH BLUFF DRIVE, SUITE 100
SAN DIEGO, CALIFORNIA 92130
(858) 792-0711
WITH A COPY TO:
JOHN C. KENNEDY, ESQ.
PAUL, WEISS, RIFKIND, WHARTON & GARRISON LLP
1285 AVENUE OF THE AMERICAS
NEW YORK, NEW YORK 10019
(212) 373-3000
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications on Behalf of the Bidder)
CALCULATION OF FILING FEE
================================================================================
TRANSACTION VALUATION(1) AMOUNT OF FILING FEE(2)
--------------------------------------------------------------------------------
$180,000,000 $14,562
================================================================================
(1) AMN Healthcare Services, Inc. intends to purchase, for cash, up to $175.0
million of its common stock, par value $0.01 per share, and up to $5.0
million of certain vested and exercisable options to purchase its common
stock.
(2) Previously paid.
[_] Check box if any part of the fee is offset as provided by Rule
0-11(a)(2) and identify the filing with which the offsetting fee was
previously paid. Identify the previous filing by registration statement
number, or the form or schedule and the date of its filing.
Amount Previously Paid: None Filing Party: N/A
Form or Registration No.: N/A Date Filed: N/A
[_] Check the box if the filing relates solely to preliminary
communications made before the commencement of a tender offer.
Check the appropriate boxes below to designate any transactions to which the
statement relates:
[_] third-party tender offer subject to Rule 14d-1.
[X] issuer tender offer subject to Rule 13e-4.
[_] going-private transaction subject to Rule 13e-3.
[_] amendment to Schedule 13D under Rule 13d-2.
Check the following box if the filing is a final amendment reporting the results
of the tender offer: [_]
This Amendment No. 3 ("Amendment No. 3") to Tender Offer Statement on
Schedule TO relates to the offer by AMN Healthcare Services, Inc., a Delaware
corporation (the "Company"), to purchase an aggregate of $180.0 million of its
securities consisting of (1) up to $175.0 million of its common stock, par value
$0.01 per share ("Shares"), at a price of $18.00 per Share, net to the seller in
cash, without interest and (2) up to $5.0 million of certain vested and
exercisable options ("Options") to purchase Shares at a price equal to $18.00,
less the applicable exercise price of such Option, net to the seller in cash,
without interest, in each case, upon the terms and subject to the conditions set
forth in the Amended and Restated Offer to Purchase, dated September 19, 2003,
and the related Letter of Transmittal, as amended. This Amendment No. 3 amends
and supplements the Schedule TO filed by the Company on September 4, 2003 and
amended on each of September 19, 2003 and October 2, 2003. This Amendment No. 3
is intended to satisfy the reporting requirements of Rule 13e-4(c)(1) of the
Securities Exchange Act of 1934.
ITEM 12. EXHIBITS.
EXHIBIT NUMBER DESCRIPTION
-------------- -----------
(a)(1)(U) Press Release, dated as of October 9, 2003,
by the Company.
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated: October 9, 2003
AMN HEALTHCARE SERVICES, INC.
By: /s/ Donald R. Myll
---------------------------------
Donald R. Myll
Chief Financial Officer and
Chief Accounting Officer
2
EXHIBIT INDEX
EXHIBIT NUMBER DESCRIPTION
-------------- -----------
(a)(1)(U) Press Release, dated as of October 9, 2003,
by the Company.